Supplementary Material for: NANLING: Roxadustat effectiveness/safety in chronic kidney disease-associated anemia with peritoneal dialysis

Supplementary Material for: NANLING: Roxadustat effectiveness/safety in chronic kidney disease-associated anemia with peritoneal dialysis

Background: Oral anemia treatments are preferred by patients on home-based peritoneal dialysis (PD). We evaluated the effectiveness and safety of oral roxadustat in Chinese patients with chronic kidney disease (CKD)-associated anemia on PD. Methods: In this phase 4 study, patients with CKD-anemia on...

Olles dieđut

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkki: figshare admin karger (2628495) (author)
Eará dahkkit: Ye Z. (3662638) (author), Xu G. (3230661) (author), Zhang H. (2945919) (author), Wang L. (3116751) (author), Yin A. (22678181) (author), Liu H. (3215136) (author), Yang X. (3341028) (author), Zhong H. (4099138) (author), Xiong F. (10154147) (author), Yang Z. (4129039) (author), Dong J. (4274044) (author), Yang H. (3112980) (author), Wu Y. (3096198) (author), Huang C. (4052749) (author), Pan S. (9562049) (author), Yu X. (2945922) (author), TheNANLINGWorkingGroup (22678184) (author)
Almmustuhtton: 2025
Fáttát:
Medicine
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Geahča maid